Day-One testing matters
Patients need access to testing immediately after a drug is launched in any country. We work with our pharma partners to ensure that companion diagnostic testing is available at drug launch in each target market.
Our commercial teams are in place in 25 countries, and we work with partners in more than 60 countries.
Our comprehensive Day-One lab readiness program facilitates CDx testing at
drug launch via a global network of partner labs. Implementation and validation
of a new test at our partner labs begins several months before CDx and drug
approval. In parallel, we run a reimbursement program and align launch
communications with our strategic partners with the goal of rapidly ramping-up
testing in shortest timeframe post-approval.